Company Overview - Meihao Medical closed at 22.73 yuan, down 19.25%, with a rolling PE ratio of 34.10 times and a total market value of 9.243 billion yuan [1] - The company operates in the medical device industry, which has an average PE ratio of 43.33 times and a median of 27.80 times, placing Meihao Medical at the 79th position in the industry ranking [1] - As of March 31, 2025, the number of shareholders for Meihao Medical was 9,334, an increase of 687 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Business Operations - Meihao Medical specializes in the design, development, manufacturing, and sales of precision components and products for medical devices [1] - The main products include home ventilator components, cochlear implant components, other medical product components, precision molds, automation equipment, and components for home and consumer electronics [1] - The company has been recognized multiple times as a "Best Supplier" by Client A and awarded "Most Valuable Service and Excellent Partner" by Client B for five consecutive years [1] Financial Performance - In the latest quarterly report for Q3 2024, Meihao Medical achieved a revenue of 1.157 billion yuan, representing a year-on-year increase of 10.86% [1] - The net profit for the same period was 258 million yuan, showing a year-on-year decrease of 14.07% [1] - The sales gross margin stood at 41.78% [1]
美好医疗收盘下跌19.25%，滚动市盈率34.10倍，总市值92.43亿元